Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Terminated 2Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 109Carcinoma, Non-Small-Cell Lung 96Prostatic Neoplasms 60Multiple Myeloma 46Neoplasms 38Neoplasm Metastasis 33Ovarian Neoplasms 26Urinary Bladder Neoplasms 24Melanoma 24Lung Neoplasms 22Recurrence 21Parkinson Disease 4, Autosomal Dominant Lewy Body 21Leukemia, Lymphocytic, Chronic, B-Cell 21Colorectal Neoplasms 21Carcinoma, Renal Cell 20Leukemia, Myeloid, Acute 17Carcinoma, Hepatocellular 17Triple Negative Breast Neoplasms 16Lymphoma, Non-Hodgkin 16Stomach Neoplasms 15Nasopharyngeal Carcinoma 15Lymphoma 14Squamous Cell Carcinoma of Head and Neck 13Small Cell Lung Carcinoma 13Fallopian Tube Neoplasms 12Colonic Neoplasms 12Carcinoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 11

Interventions

Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Neoplasm Recurrence, Local × Clear all
NCT01357772 2023-07-17

TAM-01

Ente Ospedaliero Ospedali Galliera

Phase 3 Active not recruiting
500 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡